|Bid||0.00 x 800|
|Ask||0.00 x 1000|
|Day's Range||22.65 - 24.53|
|52 Week Range||13.90 - 31.18|
|Beta (5Y Monthly)||1.06|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 24, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||32.80|
Veracyte Announces Publication of Study Using Prosigna Breast Cancer Test to Identify Patients Likely to Benefit from Aggressive Chemotherapy
If you're interested in Veracyte, Inc. (NASDAQ:VCYT), then you might want to consider its beta (a measure of share...
Veracyte (VCYT) delivered earnings and revenue surprises of -66.67% and 1.28%, respectively, for the quarter ended December 2019. Do the numbers hold clues to what lies ahead for the stock?
Veracyte, Inc., (Nasdaq: VCYT) today announced financial results and business progress for the quarter and full year ended December 31, 2019, and provided financial guidance for 2020.
The Insider Monkey team has completed processing the quarterly 13F filings for the September quarter submitted by the hedge funds and other money managers included in our extensive database. Most hedge fund investors experienced strong gains on the back of a strong market performance, which certainly propelled them to adjust their equity holdings so as […]
The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But if you buy shares in a...
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech stocks hitting 52-week highs on Dec. 3) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Antares ...
Shipping diagnostic tests over long distances is inefficient, and some countries don't allow biological material to be shipped across their borders. This South San Francisco company found another way to get it done.
NanoString, which creates devices for molecular diagnostics and research tools to understand diseases and develop drugs, will record more than $100 million in revenue this year.
Before putting in our own effort and resources into finding a good investment, we can quickly utilize hedge fund expertise to give us a quick glimpse of whether that stock could make for a good addition to our portfolios. The odds are not exactly stacked in investors' favor when it comes to beating the market, […]
How far off is Veracyte, Inc. (NASDAQ:VCYT) from its intrinsic value? Using the most recent financial data, we'll take...